Drug Type Small molecule drug |
Synonyms Inhaled fosfomycin/tobramycin, Tobramycin/fosfomycin inhalation, CORUS 1040 + [2] |
Target |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC3H7NaO4P |
InChIKeyBLLKJRKIOJQXCC-LJUKVTEVSA-N |
CAS Registry26016-99-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Fosfomycin/Tobramycin | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Phase 2 | US | 01 Nov 2008 | |
Bronchiectasis | Phase 2 | US | - | |
Bronchiectasis | Phase 2 | - | - | |
Respiratory Tract Infections | Phase 2 | US | - | |
Respiratory Tract Infections | Phase 2 | - | - |